Lymphocytic Esophagitis Masquerading as Eosinophilic Esophagitis: Diagnostic Challenges in an 85-Year-Old Patient

Document Type

Conference Proceeding

Publication Date

10-2025

Publication Title

American Journal of Gastroenterology

Abstract

Introduction: Lymphocytic esophagitis (LE) is detected in 0.1-0.3% of esophageal biopsies in America, characterized by intraepithelial lymphocyte infiltration (≥20 per high-power field) and absence of significant eosinophilia (< 15 eosinophils/hpf). While sharing symptoms with eosinophilic esophagitis (EoE), LE primarily affects women (median age 51-63 years) and exhibits nonspecific endoscopic findings, including mucosal edema, erythema, rings, or normal tissue. The etiology remains unclear, though associations with autoimmune conditions, medications, and gastroesophageal reflux have been proposed. This case describes an 85-year-old woman ultimately diagnosed with LE, highlighting the importance of considering LE outside typical demographics and the diagnostic value of histopathologic evaluation. Case Description/Methods: An 85-year-old woman with hypertension, microscopic collagenous colitis, and 3-pack-year smoking history presented with progressive solid-food dysphagia and chronic nonproductive cough. Pantoprazole 40 mg daily provided minimal symptomatic relief. She denied odynophagia, heartburn, regurgitation, weight loss, melena, NSAID use, alcohol consumption, or relevant family history. Esophagogastroduodenoscopy revealed linear furrows, rings, and mucosal friability—classic endoscopic features of EoE. However, biopsies demonstrated dense lymphocytic infiltration (>30 lymphocytes/hpf) with minimal eosinophilia (< 5 eosinophils/hpf), consistent with LE. Initial high-dose proton pump inhibitor therapy (pantoprazole 40 mg twice daily) for 8 weeks failed to achieve clinical or histologic improvement. Subsequent treatment with viscous budesonide 1 mg twice daily achieved complete symptom resolution and histologic remission within 12 weeks. Disease recurrence occurred within 4 weeks of medication discontinuation, necessitating maintenance budesonide therapy. Sustained clinical and endoscopic remission was maintained at 6-month follow-up. Discussion: This case emphasizes systematic biopsy evaluation in elderly patients with dysphagia, regardless of endoscopic findings. Only ~5% of LE patients exceed 80 years, making this case diagnostically significant. Diagnostic delays in older adults may result from symptom attribution to gastroesophageal reflux disease, medication effects, or age-related esophageal motility changes. Like EoE, LE appears to require maintenance therapy for sustained remission, suggesting chronic inflammatory pathophysiology. Future research should elucidate LE’s natural history, optimal treatment duration, and disease associations.

Volume

120

Issue

10S2

First Page

S934

Comments

American College of Gastroenterology Annual Meeting, October 24-29, 2025, Phoenix, AZ

Last Page

S934

DOI

10.14309/01.ajg.0001144936.66945.f0

Link to Full Text

Share

COinS